Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Sublingual buprenorphine and methadone maintenance treatment: a three-year follow-up of quality of life assessment.

Giacomuzzi SM, Ertl M, Kemmler G, Riemer Y, Vigl A.

ScientificWorldJournal. 2005 May 24;5:452-68.

2.
3.

Buprenorphine versus methadone maintenance treatment in an ambulant setting: a health-related quality of life assessment.

Giacomuzzi SM, Riemer Y, Ertl M, Kemmler G, Rössler H, Hinterhuber H, Kurz M.

Addiction. 2003 May;98(5):693-702.

PMID:
12751987
4.

Characteristics and quality of life of opioid-dependent pregnant women in Austria.

Metz VE, Comer SD, Wuerzl J, Pribasnig A, Fischer G.

Arch Womens Ment Health. 2014 Dec;17(6):529-39. doi: 10.1007/s00737-014-0443-6. Epub 2014 Jul 15.

5.

[Buprenorphine vs. methadone as maintenance treatment for opioid dependence].

Fischer G, Gombas W, Eder H, Jagsch R, Stühlinger G, Aschauer HN, Kasper S.

Nervenarzt. 1999 Sep;70(9):795-802. German.

PMID:
10522247
6.

Quality of life among heroin users on buprenorphine versus methadone maintenance.

Ponizovsky AM, Grinshpoon A.

Am J Drug Alcohol Abuse. 2007;33(5):631-42.

PMID:
17891656
7.

Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.

Seifert J, Metzner C, Paetzold W, Borsutzky M, Passie T, Rollnik J, Wiese B, Emrich HM, Schneider U.

Pharmacopsychiatry. 2002 Sep;35(5):159-64.

PMID:
12237786
8.

[Buprenorphine and methadone to opiate addicts--a randomized trial].

Kristensen Ø, Espegren O, Asland R, Jakobsen E, Lie Ø, Seiler S.

Tidsskr Nor Laegeforen. 2005 Jan 20;125(2):148-51. Norwegian.

9.

Comparison of buprenorphine and methadone maintenance in opiate addicts.

Eder H, Fischer G, Gombas W, Jagsch R, Stühlinger G, Kasper S.

Eur Addict Res. 1998;4 Suppl 1:3-7.

PMID:
9767199
10.

Buprenorphine versus methadone maintenance for the treatment of opioid dependence.

Fischer G, Gombas W, Eder H, Jagsch R, Peternell A, Stühlinger G, Pezawas L, Aschauer HN, Kasper S.

Addiction. 1999 Sep;94(9):1337-47.

PMID:
10615719
12.

A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence.

Ling W, Wesson DR, Charuvastra C, Klett CJ.

Arch Gen Psychiatry. 1996 May;53(5):401-7.

PMID:
8624183
13.

A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment.

Fingerhood MI, King VL, Brooner RK, Rastegar DA.

Subst Abus. 2014;35(2):122-6. doi: 10.1080/08897077.2013.819828.

PMID:
24821346
14.

A comparison of attitudes toward opioid agonist treatment among short-term buprenorphine patients.

Kelly SM, Brown BS, Katz EC, O'Grady KE, Mitchell SG, King S, Schwartz RP.

Am J Drug Alcohol Abuse. 2012 May;38(3):233-8. doi: 10.3109/00952990.2011.643983. Epub 2012 Jan 13.

15.

A preliminary study comparing methadone and buprenorphine in patients with chronic pain and coexistent opioid addiction.

Neumann AM, Blondell RD, Jaanimägi U, Giambrone AK, Homish GG, Lozano JR, Kowalik U, Azadfard M.

J Addict Dis. 2013;32(1):68-78. doi: 10.1080/10550887.2012.759872.

16.

Buprenorphine: a controlled clinical trial in the treatment of opioid dependence.

Pani PP, Maremmani I, Pirastu R, Tagliamonte A, Gessa GL.

Drug Alcohol Depend. 2000 Jul 1;60(1):39-50.

PMID:
10821988
17.

Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index.

Strain EC, Stitzer ML, Liebson IA, Bigelow GE.

J Clin Psychopharmacol. 1996 Feb;16(1):58-67.

PMID:
8834420
18.

Opioid agonist treatment for pharmaceutical opioid dependent people.

Nielsen S, Larance B, Degenhardt L, Gowing L, Kehler C, Lintzeris N.

Cochrane Database Syst Rev. 2016 May 9;(5):CD011117. doi: 10.1002/14651858.CD011117.pub2. Review.

PMID:
27157143
19.

Buprenorphine and methadone: a comparison of patient completion rates during inpatient detoxification.

Blondell RD, Smith SJ, Servoss TJ, DeVaul SK, Simons RL.

J Addict Dis. 2007;26(2):3-11.

PMID:
17594993
20.

Opioid plasma concentrations in methadone-and buprenorphine-maintained patients.

Jagsch R, Gombas W, Schindler SD, Eder H, Moody DE, Fischer G.

Addict Biol. 2005 Dec;10(4):365-71.

PMID:
16318959

Supplemental Content

Support Center